Biomarkers (8)
- Beta2-microglobulin - Beta2-microglobulin (ug/dL) (phv00159461.v2.p1)
- CRP - C-Reactive Protein (CRP) (mg/dL) (phv00159462.v2.p1)
- Hemoglobin - Hemoglobin (g/dL) (phv00159459.v2.p1)
- Platelet Count - Platelets (10^9/L) (phv00159460.v2.p1)
- Serum albumin - Serum albumin (g/dL) (phv00159469.v2.p1)
- Serum calcium - Serum calcium (mg/dL) (phv00159467.v2.p1)
- Serum creatinine - Serum creatinine (mg/dL) (phv00159466.v2.p1)
- Serum LDH - Serum LDH (U/L) (phv00159468.v2.p1)
Demographics (2)
- Age at Diagnosis - Age of the participant at the time of diagnosis of their Primary Disease (phv00159450.v2.p1)
- Gender - Participant's gender as Male or Female (phv00159451.v2.p1)
Race and Ethnicity (1)
- Race - Participant's race using US census definitions (phv00159452.v2.p1)
Other (21)
- ANALYTE_TYPE - Analyte Type (phv00159477.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00159476.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00159443.v2.p1)
- Evidence for absence of lytic lesions - Evidence for absence of lytic lesions (phv00159472.v2.p1)
- Evidence for presence of lytic lesions - Evidence for presence of lytic lesions (phv00159471.v2.p1)
- Heavy chain class - Immunoglobulin heavy chain class (phv00159456.v2.p1)
- IS_TUMOR - Tumor status (phv00159478.v2.p1)
- Light chain class - Immunoglobulin light chain class (phv00159457.v2.p1)
- Lytic lesions - Lytic lesions (phv00159470.v2.p1)
- M-spike - M-spike (g/dL) (phv00159458.v2.p1)
- Primary Disease - The main disease(s) for which the participant has been asked to donate a sample for study (phv00159454.v2.p1)
- SAMPID - De-identified Sample ID (phv00159475.v2.p1)
- SAMPID - Sample ID (phv00159445.v2.p1)
- SAMPLE_USE - Data Types generated for sample. Seq_DNA_SNP_MAF_Ind: Sample(s) were used to generate aggregate mutation annotation file (.maf) with individual SNP genotypes; Seq_DNA_SNP_MAF_Sum: Samples were used to generate aggregate mutation annotation file (.maf); Seq_DNA_WholeExome: Whole exome sequencing; Seq_DNA_WholeGenome: Whole genome sequencing (phv00201406.v1.p1)
- Serum free light chain kappa - Serum free light chain kappa (mg/dL) (phv00159463.v2.p1)
- Serum free light chain lambda - Serum free light chain lambda (mg/dL) (phv00159464.v2.p1)
- Serum free light chain ratio - Serum free light chain ratio (kappa:lambda) (phv00159465.v2.p1)
- SUBJID - Unique Participant Identifier (phv00159449.v2.p1)
- SUBJID - Subject ID (phv00159444.v2.p1)
- SUBJID - Subject ID (phv00159442.v2.p1)
- Treatment History - The participant's treatment history for Primary Disease (phv00159455.v2.p1)